Atıf Formatları
Cancer cell and Fas ligand (CD95 ligand): Immune escape or self-attack
  • IEEE
  • ACM
  • APA
  • Chicago
  • MLA
  • Harvard
  • BibTeX

D. Uckan, "Cancer cell and Fas ligand (CD95 ligand): Immune escape or self-attack," PEDIATRIC PATHOLOGY & MOLECULAR MEDICINE , vol.19, pp.223-234, 2000

Uckan, D. 2000. Cancer cell and Fas ligand (CD95 ligand): Immune escape or self-attack. PEDIATRIC PATHOLOGY & MOLECULAR MEDICINE , vol.19 , 223-234.

Uckan, D., (2000). Cancer cell and Fas ligand (CD95 ligand): Immune escape or self-attack. PEDIATRIC PATHOLOGY & MOLECULAR MEDICINE , vol.19, 223-234.

Uckan, D. "Cancer cell and Fas ligand (CD95 ligand): Immune escape or self-attack," PEDIATRIC PATHOLOGY & MOLECULAR MEDICINE , vol.19, 223-234, 2000

Uckan, D. "Cancer cell and Fas ligand (CD95 ligand): Immune escape or self-attack." PEDIATRIC PATHOLOGY & MOLECULAR MEDICINE , vol.19, pp.223-234, 2000

Uckan, D. (2000) . "Cancer cell and Fas ligand (CD95 ligand): Immune escape or self-attack." PEDIATRIC PATHOLOGY & MOLECULAR MEDICINE , vol.19, pp.223-234.

@article{article, author={D Uckan}, title={Cancer cell and Fas ligand (CD95 ligand): Immune escape or self-attack}, journal={PEDIATRIC PATHOLOGY & MOLECULAR MEDICINE}, year=2000, pages={223-234} }